PatienTrials Inc, a company of Elix Labs, aims to improve patient retention and adherence in clinical trials that results in shorter study timelines. By putting Patients First in Clinical Trials, empowering them with the information on progress of treatment at their fingertips in a community setting promotes self care. PatienTrials captures high quality patient generated data through solutions based on instant messaging, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring in clinical trials on to a HIPPA compliant instant messaging platform. Check out our solutions at https://www.patienTrials.com